Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1551195rdf:typepubmed:Citationlld:pubmed
pubmed-article:1551195lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0018801lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0887847lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C1415142lld:lifeskim
pubmed-article:1551195lifeskim:mentionsumls-concept:C0205088lld:lifeskim
pubmed-article:1551195pubmed:issue4lld:pubmed
pubmed-article:1551195pubmed:dateCreated1992-4-24lld:pubmed
pubmed-article:1551195pubmed:abstractTextIn human heart failure the positive inotropic and cAMP-elevating effects of both beta-adrenoceptor agonists and phosphodiesterase inhibitors are diminished. This has been explained at least in part by an increase in the inhibitory signal-transducing G protein (Gi) and unchanged stimulatory G protein (Gs). In the present study we determined the mRNA expression pattern of the alpha subunits of Gi-1, Gi-2, Gi-3, and Gs in myocardial tissue samples of patients undergoing heart transplantation. Northern blot analysis of total RNA extracted from left ventricles with 32P-labeled cDNAs demonstrated expression of Gi alpha-2, Gi alpha-3, and Gs alpha mRNA. In contrast, Gi alpha-1 mRNA was not detectable. To investigate whether the increased ratio of Gi/Gs might be due to altered gene expression, we compared mRNA levels of Gi alpha-2, Gi alpha-3, and Gs alpha in left ventricular myocardium from failing hearts with idiopathic dilated cardiomyopathy (n = 8) and ischemic cardiomyopathy (n = 6) and from nonfailing hearts from transplant donors (n = 8). Compared with nonfailing control hearts, the Gi alpha-2 mRNA was increased by 75 +/- 26% (p less than 0.05) in idiopathic dilated cardiomyopathy hearts and 90 +/- 26% (p less than 0.05) in ischemic cardiomyopathy hearts. Gi alpha-3 and Gs alpha mRNA levels were similar in the three groups. The results suggest that as in other mammalian species, Gi alpha-2 and Gi alpha-3 mRNA are the predominant Gi alpha mRNA subtypes in human ventricular myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1551195pubmed:languageenglld:pubmed
pubmed-article:1551195pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1551195pubmed:citationSubsetIMlld:pubmed
pubmed-article:1551195pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1551195pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1551195pubmed:statusMEDLINElld:pubmed
pubmed-article:1551195pubmed:monthAprlld:pubmed
pubmed-article:1551195pubmed:issn0009-7330lld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:MOENH MHMlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:ScholzHHlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:SchmitzWWlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:DöringVVlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:KalmárPPlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:HaverichAAlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:MendeUUlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:EschenhagenTTlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:HöppnerWWlld:pubmed
pubmed-article:1551195pubmed:authorpubmed-author:HirtSSlld:pubmed
pubmed-article:1551195pubmed:issnTypePrintlld:pubmed
pubmed-article:1551195pubmed:volume70lld:pubmed
pubmed-article:1551195pubmed:ownerNLMlld:pubmed
pubmed-article:1551195pubmed:authorsCompleteNlld:pubmed
pubmed-article:1551195pubmed:pagination688-96lld:pubmed
pubmed-article:1551195pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:meshHeadingpubmed-meshheading:1551195-...lld:pubmed
pubmed-article:1551195pubmed:year1992lld:pubmed
pubmed-article:1551195pubmed:articleTitleIncreased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure.lld:pubmed
pubmed-article:1551195pubmed:affiliationAbteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Universität Hamburg, FRG.lld:pubmed
pubmed-article:1551195pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1551195pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1551195pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1551195pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1551195lld:pubmed